These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Booth J; Connelly L; Dickson S; Duncan F; Lawrence M Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583 [TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial. Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804 [TBL] [Abstract][Full Text] [Related]
30. Electrical and mechanical office-based neuromodulation. Kacker R; Lay A; Das A Urol Clin North Am; 2013 Nov; 40(4):581-9. PubMed ID: 24182977 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital. Jiang JF; Leung AK; Pettitt-Schieber B; Nabavizadeh R; Thomas RL; Brown M; Hafford D; Lay AH; Hammett J; Carney KJ; Filson CP; Master VA J Urol; 2020 Feb; 203(2):385-391. PubMed ID: 31518202 [TBL] [Abstract][Full Text] [Related]
32. [What to do if pills do not work for urge incontinence--still many questions and ambiguities]. Koldewijn EL Ned Tijdschr Geneeskd; 2012; 156(33):A5099. PubMed ID: 22894810 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of the percutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms]. Kozma B; Majoros A; Pytel Á; Póka R; Takács P Orv Hetil; 2018 Oct; 159(43):1735-1740. PubMed ID: 30346235 [TBL] [Abstract][Full Text] [Related]
34. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. van Breda HMK; Martens FMJ; Tromp J; Heesakkers JPFA J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576 [TBL] [Abstract][Full Text] [Related]
35. Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States. Kraus SR; Shiozawa A; Szabo SM; Qian C; Rogula B; Hairston J Neurourol Urodyn; 2020 Nov; 39(8):2206-2222. PubMed ID: 32827230 [TBL] [Abstract][Full Text] [Related]
36. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report. Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104 [TBL] [Abstract][Full Text] [Related]
38. Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder. Tipton WA; de Riese WTW; de Riese CS Urol Pract; 2020 Nov; 7(6):530-537. PubMed ID: 37287172 [TBL] [Abstract][Full Text] [Related]
39. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. MacDiarmid SA; Peters KM; Shobeiri SA; Wooldridge LS; Rovner ES; Leong FC; Siegel SW; Tate SB; Feagins BA J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821 [TBL] [Abstract][Full Text] [Related]
40. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome. Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]